Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study

被引:7
|
作者
Kim, Mihui [1 ]
Yang, Yong Sook [1 ]
Ko, Young-Guk [2 ]
Choi, Mona [3 ]
机构
[1] Yonsei Univ, Coll Nursing, Brain Korea 21 4 Project, Seoul 03722, South Korea
[2] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul 03722, South Korea
[3] Yonsei Univ, Mo Im Kim Nursing Res Inst, Coll Nursing, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
diabetes mellitus; exercise; major adverse cardiovascular event; major adverse limb event; peripheral artery disease; CHRONIC KIDNEY-DISEASE; PHYSICAL-ACTIVITY; RISK-FACTORS; ASSOCIATION; EPIDEMIOLOGY; MECHANISMS; EXERCISE; SYSTEM;
D O I
10.3390/jcm11092547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: For peripheral artery disease (PAD) patients, after endovascular revascularization, it is crucial to manage associated factors that can affect the risk of major adverse events. We aimed to investigate the associated factors of major adverse events in these patients. Materials and Methods: We conducted a retrospective longitudinal analysis using the electronic medical records from a tertiary hospital in Korea and included the data of 1263 patients. Eligible patients were categorized into four groups based on diabetes mellitus (DM) and regular exercise. The major adverse events included major adverse limb events and major adverse cardiovascular events. Major adverse events-free survival was assessed using the Kaplan-Meier method, and associated factors of major adverse events were analyzed using Cox proportional hazards analyses. Results: Kaplan-Meier survival curves showed that patients with DM and non-regular exercise had a shorter major adverse events-free survival. The Cox regression analysis showed that for patients with critical limb ischemia or chronic kidney disease, the risk of major adverse events increased, while group variables were not significant. Conclusion: Target management of patients with DM, critical limb ischemia, and chronic kidney disease is essential to reduce major adverse events after endovascular revascularization in patients with PAD.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Association of Anticoagulation and Major Adverse Limb Events After Index Peripheral Endovascular Intervention
    Ramkumar, Niveditta
    Goodney, Philip P.
    Creager, Mark A.
    Henkin, Stanislav
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 192 : 124 - 131
  • [32] Major adverse cardiovascular events in patients presenting significant renal artery stenosis after renal interventional revascularization
    Geavlete, D. O.
    Beladan, C.
    Platon, P.
    Tautu, O.
    Zaharia, M. R.
    Popescu, B. A.
    Ginghina, C.
    Chioncel, O.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1212 - 1212
  • [33] Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease
    Ariel Berger
    Alex Simpson
    Nicholas J. Leeper
    Brian Murphy
    Beth Nordstrom
    Windsor Ting
    Qi Zhao
    Jeffrey Berger
    Advances in Therapy, 2020, 37 : 240 - 252
  • [34] Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease
    Berger, Ariel
    Simpson, Alex
    Leeper, Nicholas
    Murphy, Brian
    Nordstrom, Beth
    Ting, Windsor
    Zhao, Qi
    Berger, Jeffrey
    ADVANCES IN THERAPY, 2020, 37 (01) : 240 - 252
  • [35] Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease
    Morrison, Justin T.
    Govsyeyev, Nicholas
    Hess, Connie N.
    Bonaca, Marc P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [36] The Association between Major Adverse Cardiovascular Events and Peripheral Artery Disease Burden
    Niiranen, Oskari
    Virtanen, Juha
    Rantasalo, Ville
    Ibrahim, Amer
    Venermo, Maarit
    Hakovirta, Harri
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (06)
  • [37] IMPACT OF COMORBID CORONARY ARTERY DISEASE AND SEVERE PERIPHERAL ARTERY DISEASE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS
    Ting, Windsor
    Zhao, Qi
    Haskell, Lloyd
    Lurie, Fedor
    Berger, Jeffrey
    Eapen, Zubin
    Valko, Matthew
    Alas, Veronica
    Rich, Kelly
    Crivera, Concetta
    Schein, Jeff
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1390 - 1390
  • [38] GAIT BIOMECHANICS IN PATIENTS WITH PERIPHERAL ARTERY DISEASE AFTER REVASCULARIZATION
    Baker, S.
    Myers, S. A.
    Pipinos, I.
    Johanning, J.
    GERONTOLOGIST, 2016, 56 : 103 - 103
  • [39] Lower May Not Be Better: Systolic Blood Pressure and Risk of Major Adverse Limb Events in Patients With Symptomatic Peripheral Artery Disease After Revascularization: Insights From Voyager Pad
    Buchanan, Cullen E.
    Szarek, Michael
    Debus, Sebastian
    Patel, Manesh R.
    Nehler, Mark
    Anand, Sonia S.
    Hess, Connie
    Hsia, Judith A.
    Muehlhofer, Eva
    Haskell, Lloyd P.
    Berkowitz, Scott D.
    Bauersachs, Rupert
    Bonaca, Marc P.
    CIRCULATION, 2022, 146
  • [40] Patient and limb outcomes 10 years after endovascular revascularization of the superficial femoral artery for peripheral artery disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) study
    Kinlay, Scott
    Sobieszczyk, Piotr
    Eisenhauer, Andrew C.
    Ostrowski, Simon
    Todoran, Thomas M.
    VASCULAR MEDICINE, 2023, 28 (04) : 290 - 298